G

Gentian Diagnostics ASA
OSE:GENT

Watchlist Manager
Gentian Diagnostics ASA
OSE:GENT
Watchlist
Price: 41 NOK 6.22% Market Closed
Market Cap: 632.3m NOK
Have any thoughts about
Gentian Diagnostics ASA?
Write Note

Gentian Diagnostics ASA
Investor Relations

Gentian Diagnostics ASA is a medical diagnostics company. The company is headquartered in Moss, Ostfold. The company went IPO on 2016-12-14. The firm develops and manufactures in vitro diagnostic (IVD) products for the detection and quantification of specific markers for use on a wide range of clinical chemistry analysers. The Company’s product portfolio comprises turbidimetric fecal calprotectin immunoassay, which is to be run on clinical chemistry analysers: The Gentian Calprotectin Immunoassay, Cystatin C, NT-proBNP - Pre-launch, SARS-CoV-2 Ab Pre-Launch, Canine CRP and Beckman Coulter Customers. The firm is based in Moss, Norway, serving the global human and veterinary diagnostics markets through sales and representative offices in Sweden, USA and China.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Dr. Hilja Ibert
Executive Chairperson
No Bio Available
Mr. Njaal Kind
Acting CEO, CFO & COO
No Bio Available
Dr. Aleksandra Havelka
Chief Scientific Officer
No Bio Available
Mr. Markus Jaquemar
Chief Commercial Officer
No Bio Available
Dr. Ingo Curdt
Head of Innovation & Research
No Bio Available
Dr. Tom Nilsen
Head of Product Development
No Bio Available

Contacts

Address
OSTFOLD
Moss
Bjornasveien 5
Contacts
+4799339905
www.gentian.com